Medtronic reports third quarter fiscal 2025 financial results

Go back to Medtronic reports third quarter fiscal 2025 financial results

Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT)

February 18, 2025 8:13 AM EST

Raymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).

The analyst comments "F3Q results were mixed, as revenue missed and adj. EPS beat. The primary revenue variance (vs. RJe/consensus) was in Surgical, which... More